Drugs for reducing the amount of iron supplements used in the treatment, improvement, or prevention of iron deficiency anemia
JP2026111524APending Publication Date: 2026-07-03KRACIE CO LTD
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- KRACIE CO LTD
- Filing Date
- 2025-12-04
- Publication Date
- 2026-07-03
AI Technical Summary
Technical Problem
Existing treatments for iron deficiency anemia, including iron supplements, suffer from low absorption efficiency and significant side effects, necessitating high doses and impacting patient quality of life.
Method used
Combining iron supplements with Ninjin'yoeito, a traditional Japanese herbal medicine, to enhance iron absorption by promoting ferroportin expression and reducing side effects through improved iron excretion.
Benefits of technology
Reduces the dosage of iron supplements required while maintaining therapeutic effects, enhancing iron absorption, and minimizing side effects such as gastrointestinal issues and iron overload.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure 2026111524000001_ABST
Abstract
This paper provides a new treatment for iron deficiency anemia and a method to mitigate the side effects of existing treatments. [Solution] The present inventors, after diligent research to solve the above problems, have found that by using iron supplements and Ninjin-yoeito (a traditional Japanese herbal medicine) in combination for iron deficiency anemia, the dosage of iron supplements can be reduced while maintaining therapeutic effects, and side effects can be reduced as iron is less likely to accumulate in the duodenum. The present invention provides a drug containing Ninjin-yoeito for reducing the amount of iron supplements used in the treatment, improvement, or prevention of iron deficiency anemia. The present invention also provides an iron absorption enhancer containing Ninjin-yoeito.
Need to check novelty before this filing date? Find Prior Art